NeuroMetrix Current Ratio 2010-2024 | NURO
NeuroMetrix current ratio from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
NeuroMetrix Current Ratio Historical Data |
Date |
Current Assets |
Current Liabilities |
Current Ratio |
2024-12-31 |
$0.02B |
$0.00B |
14.83 |
2024-09-30 |
$0.02B |
$0.00B |
13.88 |
2024-06-30 |
$0.02B |
$0.00B |
11.62 |
2024-03-31 |
$0.02B |
$0.00B |
10.91 |
2023-12-31 |
$0.02B |
$0.00B |
16.81 |
2023-09-30 |
$0.02B |
$0.00B |
16.43 |
2023-06-30 |
$0.02B |
$0.00B |
18.42 |
2023-03-31 |
$0.02B |
$0.00B |
16.29 |
2022-12-31 |
$0.02B |
$0.00B |
21.79 |
2022-09-30 |
$0.02B |
$0.00B |
12.79 |
2022-06-30 |
$0.03B |
$0.00B |
15.51 |
2022-03-31 |
$0.03B |
$0.00B |
14.81 |
2021-12-31 |
$0.02B |
$0.00B |
17.71 |
2021-09-30 |
$0.03B |
$0.00B |
14.72 |
2021-06-30 |
$0.01B |
$0.00B |
6.34 |
2021-03-31 |
$0.01B |
$0.00B |
3.34 |
2020-12-31 |
$0.01B |
$0.00B |
3.10 |
2020-09-30 |
$0.01B |
$0.00B |
3.06 |
2020-06-30 |
$0.01B |
$0.00B |
3.06 |
2020-03-31 |
$0.01B |
$0.00B |
1.69 |
2019-12-31 |
$0.01B |
$0.00B |
1.58 |
2019-09-30 |
$0.01B |
$0.00B |
1.70 |
2019-06-30 |
$0.01B |
$0.01B |
1.83 |
2019-03-31 |
$0.01B |
$0.01B |
2.58 |
2018-12-31 |
$0.01B |
$0.01B |
1.76 |
2018-09-30 |
$0.01B |
$0.00B |
3.01 |
2018-06-30 |
$0.01B |
$0.00B |
2.78 |
2018-03-31 |
$0.01B |
$0.00B |
2.53 |
2017-12-31 |
$0.01B |
$0.01B |
1.99 |
2017-09-30 |
$0.01B |
$0.00B |
1.93 |
2017-06-30 |
$0.01B |
$0.00B |
2.12 |
2017-03-31 |
$0.01B |
$0.00B |
3.41 |
2016-12-31 |
$0.01B |
$0.00B |
2.29 |
2016-09-30 |
$0.01B |
$0.00B |
2.95 |
2016-06-30 |
$0.01B |
$0.00B |
4.74 |
2016-03-31 |
$0.01B |
$0.00B |
3.51 |
2015-12-31 |
$0.02B |
$0.00B |
4.67 |
2015-09-30 |
$0.01B |
$0.00B |
3.38 |
2015-06-30 |
$0.02B |
$0.00B |
4.46 |
2015-03-31 |
$0.01B |
$0.00B |
2.48 |
2014-12-31 |
$0.01B |
$0.00B |
4.11 |
2014-09-30 |
$0.01B |
$0.00B |
5.23 |
2014-06-30 |
$0.02B |
$0.00B |
6.40 |
2014-03-31 |
$0.01B |
$0.00B |
4.70 |
2013-12-31 |
$0.01B |
$0.00B |
6.41 |
2013-09-30 |
$0.01B |
$0.00B |
5.01 |
2013-06-30 |
$0.01B |
$0.00B |
5.31 |
2013-03-31 |
$0.01B |
$0.00B |
4.45 |
2012-12-31 |
$0.01B |
$0.00B |
5.27 |
2012-09-30 |
$0.01B |
$0.00B |
5.09 |
2012-06-30 |
$0.02B |
$0.00B |
6.32 |
2012-03-31 |
$0.02B |
$0.00B |
7.52 |
2011-12-31 |
$0.01B |
$0.00B |
4.48 |
2011-09-30 |
$0.02B |
$0.00B |
5.22 |
2011-06-30 |
$0.02B |
$0.00B |
7.58 |
2011-03-31 |
$0.02B |
$0.00B |
7.62 |
2010-12-31 |
$0.02B |
$0.00B |
8.16 |
2010-09-30 |
$0.03B |
$0.00B |
7.24 |
2010-06-30 |
$0.03B |
$0.00B |
7.81 |
2010-03-31 |
$0.03B |
$0.00B |
8.11 |
2009-12-31 |
$0.04B |
$0.00B |
8.67 |
2009-09-30 |
$0.04B |
$0.01B |
7.94 |
2009-06-30 |
$0.03B |
$0.01B |
5.11 |
2009-03-31 |
$0.03B |
$0.01B |
5.47 |
Sector |
Industry |
Market Cap |
Revenue |
Medical |
MED PRODUCTS |
$0.009B |
$0.003B |
Neurometrix is a medical device company establishing a new standard of care through the design, development and sale of proprietary products used to diagnose neuropathies. Neuropathies are diseases of the peripheral nerves and parts of the spine that frequently are caused by or associated with diabetes, low back pain and carpal tunnel syndrome, as well as other clinical disorders.
|